EuroVIR
| Reference number | |
| Coordinator | Annexin Pharmaceuticals AB |
| Funding from Vinnova | SEK 22 365 |
| Project duration | February 2015 - March 2015 |
| Status | Completed |
Important results from the project
Annexin Pharmaceuticals wants to explore a potential collaboration with Enyo Pharma SA and to seef funding from Eurostars.
Expected long term effects
We met with the management of Enyo Pharmas and discussed a potential collaboration. The parties agreed to continue the dialouge and and evaluate a potential collaboration (Eurostars).
Approach and implementation
The management and owners of Annexin Pharmaceuticals traveled to Enyo Pharma in Lyon for a full day meeting on February 17.